Home About us Services Contact
 

News

Looking ahead to the upcoming earnings release, analysts anticipate revenue growth of 4.4 % year‑over‑year and adjusted earnings of $1.58 per share. This follows a 1.3 % revenue miss in the previous quarter. Disney’s share price of $112.99 offers a potential upside relative to the average analyst target of $132.23. The company remains a stable play...
Full article
02/02/2026 | The Walt Disney Company
Fiscal Q4 2025 results revealed a 6 % decline in the Entertainment division’s revenue and a 21 % drop in linear networks operating income, though the direct‑to‑consumer streaming arm posted $352 million in operating income. Total revenue for 2025 rose 3 % to $94.4 billion, with Q4 revenue flat at $22.5 billion. Income before taxes more than doubled...
Full article
02/02/2026 | The Walt Disney Company
The succession vote underscores the broader impact on Disney’s content spending, park investments and streaming strategy. The current share price is trading roughly 15 % below analyst targets, heightening scrutiny of how a new CEO will allocate capital, manage costs and prioritize growth across film studios, theme parks and consumer products.
Full article
02/02/2026 | The Walt Disney Company
Disney’s fiscal first‑quarter results are slated for release on February 2, with analysts expecting revenue to rise 4 % and earnings per share to fall 10 %. Investors will also watch the board’s vote on Bob Iger’s successor, as internal candidates Josh D’Amaro and Dana Walden are seen as frontrunners. The company is expected to update on theme‑park...
Full article
02/02/2026 | The Walt Disney Company
In response, FLWS is sharpening its demand‑generation model, aiming to improve marketing contribution margin and efficiency. The firm is also expanding third‑party marketplace partnerships (Uber, DoorDash, Amazon, and Walmart.com), thereby driving customer reach and offsetting decline in its traditional channels. A loyalty‑program upgrade is slat...
Full article
30/01/2026 | 1-800-FLOWERS.COM, Inc.
Management highlighted a $15 million annualized run‑rate cost‑saving initiative for fiscal 2026, achieved through simplifying the organization and boosting operational efficiency. These savings come as a compensatory lever to offset revenue shortfalls, particularly in direct traffic and search‑engine visibility, which have weakened the company’s t...
Full article
30/01/2026 | 1-800-FLOWERS.COM, Inc.
1‑800‑Flowers.com (NASDAQ: FLWS) reported Q2 2026 earnings of $1.20 per share, beating the consensus estimate of $0.92 by 39.54 %. Revenue for the period was $702.18 million, a 0.23 % lift over expectations but still 9.2 % below the $775.49 million reported a year earlier. The company’s gross margin fell because of lower fixed‑cost absorption, hig...
Full article
30/01/2026 | 1-800-FLOWERS.COM, Inc.
The appointment coincides with the firm’s ongoing development of its telomere‑analysis platform, which underpins Telo Genomics’ diagnostic and prognostic tests. The company maintains a portfolio of over 160 peer‑reviewed publications and more than 30 clinical studies involving in excess of 3,000 patients. Its flagship product, Telo‑MM, is advanci...
Full article
30/01/2026 | Telomir Pharmaceuticals, Inc.
Telo Genomics Corp. (TSXV: TELO) announced that John Price will assume the role of Chief Financial Officer effective January 30 , 2026. Price comes with more than 30 years of experience in accounting operations, financial planning, mergers and acquisitions, and capital markets, and holds a B.S. in Accounting from Pennsylvania State University. He...
Full article
30/01/2026 | Telomir Pharmaceuticals, Inc.
AOSL has a track record of exceeding consensus EPS estimates, having outperformed in the last four quarters. With a Zacks Rank of #2 (Buy) and the high ESP, analysts remain bullish on the company’s earnings prospects. The forthcoming February 5 results are expected to confirm a consensus‑EPS beat.
Full article
30/01/2026 | Alpha and Omega Semiconductor Limited